Explore All 1292 Growth Capital Software Deals - Search the Database Free
Investment Summary |
|
|---|---|
| Date | November 6, 2018 |
| Target | Messagepoint |
| Sector | Software |
| Investor(s) | NewSpring Capital |
| Deal Type | Growth Capital |
FILTER BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1999 |
| PE ASSETS | 3.5B USD |
| Size | Large |
| Type | Sector Agnostic |
NewSpring Capital is a private investment firm focused on growth companies in the Mid-Atlantic US. The Firm can provide both growth equity and junior capital to prospective companies. NewSpring's target investment size for both mezzanine and equity financing is $2 to $5 million, although for new ventures, the Firm can commit up to $10 million. Sectors of interest include specialty manufacturing, technology, business services, information technology, life science, healthcare services, and medical devices. NewSpring Capital was formed in 1999 and is based in Radnor, Pennsylvania with an additional office in Short Hills, New Jersey.
| Deal Context for Investor | # |
|---|---|
| Overall | 131 of 201 |
| Sector: Software | 12 of 15 |
| Type: Growth Capital | 61 of 106 |
| State: Ontario | 1 of 2 |
| Country: Canada | 1 of 2 |
| Year: 2018 | 9 of 9 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-11-01 |
AUC Group
Houston, Texas, United States AUC Group LP is a provider of a wastewater treatment and water reuse solutions primarily to property developers and municipal customers, including utility districts, in the United States. AUC Group was founded in 1970 and is based in Houston, Texas. |
Sell | $130M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-12-05 |
Aisthesis
Bethesda, Maryland, United States Aisthesis provides anesthesiology services to Ambulatory Surgery Centers (ASCs) in the greater Washington D.C. metro area. ASCs perform minor surgeries and medical procedures that would otherwise be performed in hospitals at greater cost and less convenience. Anesthesia's board-certified anesthesiologists perform their services with drugs that produce fewer side effects to patients resulting in shorter recovery times and increased facility utilization for the ASCs. |
Sell | - |